Eotaxin-3/CCL26 gene expression in intestinal epithelial cells is up-regulated by interleukin-4 and interleukin-13 via the signal transducer and activator of transcription 6

被引:65
作者
Blanchard, C
Durual, S
Estienne, M
Emami, S
Vasseur, S
Cuber, JC [1 ]
机构
[1] INSERM, Fac Med Laennec, F-69372 Lyon, France
[2] Hop St Antoine, INSERM, U482, F-75571 Paris, France
[3] INSERM, U624, F-13009 Marseille, France
关键词
cytokines; eotaxin-3; transcription factors; gene regulation; signal transduction; mucosa inflammation;
D O I
10.1016/j.biocel.2005.06.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Several inflammatory processes of the bowel are characterized by an accumulation of eosinophils at sites of inflammation. The mechanisms that govern mucosal infiltration with eosinophils are not fully understood. Eotaxin-3/CCL-26 belongs to a family of CC chemokines, which are potent chemoattractants for eosinophils. In this study, we hypothesized that intestinal epithelia] cells could release eotaxin-3. We demonstrate that the T helper 2 type cytokines interleukin-4 or interleukin-13 increase eotaxin-3 mRNA levels and eotaxin-3 protein expression in the human intestinal epithelial cell lines HT-29 CL.19A and T84 in a dosedependent manner. Addition of actinomycin-D prior to interleukin-4/-13 stimulation led to decreases in eotaxin-3 mRNA levels similar to those observed in controls without interleukin-4/-13. Interleukin-4 and interleukin-13 activated signal transducer and activator of transcription 6 which was found to bind the two canonical signal transducer and activator of transcription 6 binding sites located in the eotaxin-3 promoter. Experiments with the eotaxin-3 promoter luciferase constructs revealed that the most proximal signal transducer and activator of transcription 6 binding site located between positions -62 and -71 relative to the transcriptional start was necessary for full eotaxin-3 promoter activity. Importantly, we present evidence that the signal transducer and activator of transcription 6 is necessary and sufficient for interleukin-4 or interleukin-13 mediated eotaxin-3 gene up-regulation using HT-29 CL. 19A cells expressing a dominant-negative signal transducer and activator of transcription 6. Overall, these results demonstrate that epithelial eotaxin-3 is up-regulated in the context of a T helper 2 mediated inflammatory bowel disease via the signal transducer and activator of transcription 6, thus suggesting that the intestinal epithelium actively participates in the recruitment of eosinophils at the site of inflammation. (c) 2005 Published by Elsevier Ltd.
引用
收藏
页码:2559 / 2573
页数:15
相关论文
共 45 条
[1]  
AUGERON C, 1984, CANCER RES, V44, P3961
[2]   Regulation of human eotaxin-3/CCL26 expression: Modulation by cytokines and glucocorticoids [J].
Banwell, ME ;
Tolley, NS ;
Williams, TJ ;
Mitchell, TJ .
CYTOKINE, 2002, 17 (06) :317-323
[3]   Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 hours after allergen challenge [J].
Berkman, N ;
Ohnona, S ;
Chung, FK ;
Breuer, R .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2001, 24 (06) :682-687
[4]   IL-4 and IL-13 up-regulate intestinal trefoil factor expression: Requirement for STAT6 and de novo protein synthesis [J].
Blanchard, C ;
Durual, S ;
Estienne, M ;
Bouzakri, K ;
Heim, MH ;
Blin, N ;
Cuber, JC .
JOURNAL OF IMMUNOLOGY, 2004, 172 (06) :3775-3783
[5]   Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4 [J].
Boirivant, M ;
Fuss, IJ ;
Chu, A ;
Strober, W .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (10) :1929-1939
[6]   The immunological and genetic basis of inflammatory bowel disease [J].
Bouma, G ;
Strober, W .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (07) :521-533
[7]   Interleukins 4 and 13 increase intestinal epithelial permeability by a phosphatidylinositol 3-kinase pathway - Lack of evidence for STAT 6 involvement [J].
Ceponis, PJM ;
Botelho, F ;
Richards, CD ;
McKay, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (37) :29132-29137
[8]   Cloning, expression, and characterization of the human eosinophil eotaxin receptor [J].
Daugherty, BL ;
Siciliano, SJ ;
DeMartino, JA ;
Malkowitz, L ;
Sirotina, A ;
Springer, MS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (05) :2349-2354
[9]  
Denning GM, 1996, J IMMUNOL, V156, P4807
[10]  
DHARMSATHAPHORN K, 1984, AM J PHYSIOL, V246, P204